Home » Topics » BioWorld Science

BioWorld Science
RSS

Emapalumab and anakinra studied to reduce hyperinflammation and respiratory distress in COVID-19

April 8, 2020

FDA clears Polaryx's IND for PLX-200 in juvenile neuronal ceroid lipofuscinosis

April 8, 2020

New nitrofuran-class antibiotic IITR-06144 shows efficacy against resistant bacteria

April 8, 2020

Biogen describes new OGA inhibitors

April 8, 2020

New USP9X inhibitors identified by FORMA Therapeutics

April 8, 2020

Investigator-initiated IND application filed to study CORVax12 to prevent COVID-19

April 8, 2020

Forge Therapeutics presents new bacterial LpxC inhibitors

April 8, 2020

Beijing Yuezhikangtai Biomedicines discloses VEGFR inhibitors

April 8, 2020

Roche patents Toll-like receptor antagonists

April 8, 2020

Preclinical data support development of WZ-66 for NASH

April 8, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...